Clinical research organisation Parexel International has acquired ClinIntel, a UK-based group specialised in clinical Randomisation and Trial Supply Management (RTSM).
ClinIntel’s service is designed to make patient randomisation and clinical supply chains more efficient. The package includes services for planning, forecasting and supply chain eLogistics. ClinIntel was founded in 2009, and works with biopharmaceutical companies and contract research organisations.
Josef von Rickenbach, Chairman and CEO of Parexel International stated, “As the use of technology has expanded in the conduct of clinical research, Parexel has been a leader in Randomisation and Trial Supply Management. By combining the trial supply management technologies from ClinIntel with our existing ClinPhone solutions, we believe we have an opportunity to further advance our position as a clinical technology leader and grow market share by bringing enhanced speed, efficiency, and simplicity to our RTSM offering.”